{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:36:24Z","timestamp":1777354584614,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:58:40Z","timestamp":1750255120000},"page":"1243-1255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-6637","authenticated-orcid":false,"given":"Asia","family":"Sikora Kessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-805X","authenticated-orcid":false,"given":"T. Michelle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0582-9195","authenticated-orcid":false,"given":"Emily","family":"Bratlee-Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheri","family":"Fehnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Vera-Llonch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-9209","authenticated-orcid":false,"given":"Maurizio","family":"Averna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-8126","authenticated-orcid":false,"given":"Seth J.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-8024","authenticated-orcid":false,"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"Mu\u00f1iz-Grijalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9834-9494","authenticated-orcid":false,"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.jacl.2025.06.014_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-008-0005-1","article-title":"Hypertriglyceridemia: phenomics and genomics","volume":"326","author":"Hegele","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"19","key":"10.1016\/j.jacl.2025.06.014_bib0002","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/2047487319888054","article-title":"Prevalence of familial chylomicronemia syndrome in a quaternary care center","volume":"27","author":"Pallazola","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.014_bib0003","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4158\/EP-2018-0157","article-title":"Familial chylomicronemia syndrome: a clinical guide for endocrinologists","volume":"24","author":"Falko","year":"2018","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.jacl.2025.06.014_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HCO.0000000000000839","article-title":"Genetics of hypertriglyceridemia and atherosclerosis","volume":"36","author":"Gill","year":"2021","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.014_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12944-020-01302-x","article-title":"The burden of familial chylomicronemia syndrome in Canadian patients","volume":"19","author":"Gaudet","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.014_bib0006","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacl.2018.04.009","article-title":"The burden of familial chylomicronemia syndrome: results from the global IN-FOCUS study","volume":"12","author":"Davidson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.06.014_bib0007","unstructured":"FCS Focus. About familial chylomicronemia syndrome. 2021. Accessed February 14, 2022. https:\/\/fcsfocus.com\/what-is-fcs\/."},{"key":"10.1016\/j.jacl.2025.06.014_bib0008","unstructured":"FCS Foundation. About familial chylomicronemia syndrome (FCS). 2017. Accessed February 14, 2022. https:\/\/www.livingwithfcs.org\/About-FCS."},{"issue":"6","key":"10.1016\/j.jacl.2025.06.014_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.014_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14779072.2020.1748011","volume":"18","author":"Fox","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.014_bib0011","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11136-022-03266-0","article-title":"Qualitative development of the PROMIS profile v1.0-familial chylomicronemia Syndrome (FCS) 28","volume":"32","author":"Kaiser","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.014_bib0012","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13023-023-02927-8","article-title":"Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience","volume":"18","author":"Williams","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.014_bib0013","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacl.2018.05.013","article-title":"Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study","volume":"12","author":"Blom","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.06.014_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.002","article-title":"Diagnostic algorithm for familial chylomicronemia syndrome","volume":"23","author":"Stroes","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.014_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: bringing to life dietary recommendations throughout the life span","volume":"12","author":"Williams","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.014_bib0016","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17446651.2024.2365787","article-title":"Etiology and emerging treatments for familial chylomicronemia syndrome","volume":"19","author":"Spagnuolo","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.jacl.2025.06.014_bib0017","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.014_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s41687-021-00347-5","article-title":"Development of a novel PRO instrument for use in familial chylomicronemia syndrome","volume":"5","author":"Davidson","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.014_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1020909529486","article-title":"A purposeful approach to the constant comparative method in the analysis of qualitative interviews","volume":"36","author":"Boeije","year":"2002","journal-title":"Qual Quant"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.014_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.jacl.2025.06.014_bib0021","unstructured":"ClinicalTrials.gov. A study of olezarsen (formerly known as AKCEA-APOCIII-LRx) in participants with familial chylomicronemia syndrome (FCS). NCT05130450. 2024. Accessed November 8, 2024. https:\/\/clinicaltrials.gov\/study\/NCT05130450?a=2."},{"key":"10.1016\/j.jacl.2025.06.014_bib0022","unstructured":"Food and Drug Administration (FDA). FDA approves drug to reduce triglycerides in adult patients with familial chylomicronemia syndrome. 2024. Accessed 16 May 2025. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-drug-reduce-triglycerides-adult-patients-familial-chylomicronemia-syndrome."},{"key":"10.1016\/j.jacl.2025.06.014_bib0023","unstructured":"Food and Drug Administration (FDA). Patient-focused Drug development: methods to identify what is important to patients guidance for industry, Food and Drug Administration staff, and other stakeholders. 2022. Accessed 08 May 2025. https:\/\/www.fda.gov\/media\/131230\/download."},{"issue":"7","key":"10.1016\/j.jacl.2025.06.014_bib0024","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","article-title":"Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development","volume":"21","author":"Turner-Bowker","year":"2018","journal-title":"Value Health"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T01:46:02Z","timestamp":1764035162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1933287425003253"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.014","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}